SciClone Pharmaceuticals Inc., (HKG: 6600), a prominent player in China’s pharmaceutical industry, has joined forces with SPH Health Commerce Co., Ltd and Hi Dr to establish an Internet hospital. The tripartite partnership aims to leverage digital healthcare solutions, although no financial details of the agreement have been disclosed.
SciClone, known for its go-to-patient (GTP) model, specializes in sponsoring star drug brands that are predominantly marketed outside traditional hospital channels. This new venture signifies the company’s strategic expansion into the digital healthcare sector, aligning with the growing trend of online medical services in China.- Flcube.com
